Document is current
Any future updates will be listed below
-
Authors
Warmbrunn, Moritz V.
Attaye, Ilias
Horak, Anthony
Banerjee, Rakhee
Massey, William J.
Varadharajan, Venkateshwari
Rampanelli, Elena https://orcid.org/0000-0002-7742-0092
Hao, Youling
Dutta, Sumita
Nemet, Ina
Aron-Wisnewsky, Judith
Clément, Karine
Koopen, Annefleur
Wortelboer, Koen https://orcid.org/0000-0002-3582-0127
Bergh, Per-Olof
Davids, Mark https://orcid.org/0000-0003-3081-9124
Mohamed, Nadia
Kemper, E. Marleen
Hazen, Stanley https://orcid.org/0000-0001-7124-6639
Groen, Albert K.
van Raalte, Daniel H.
Herrema, Hilde
Backhed, Fredrik
Brown, J. Mark
Nieuwdorp, Max
- License Information
-
More Information
Article History
Received: 25 February 2024
Accepted: 23 October 2024
First Online: 4 November 2024
Competing interests
: M.N. is a member of the scientific advisory board of Caelus Health and all honoraria are paid to the employer Amsterdam University Medical Centres. F.B. receives research funding from Biogaia AB, is co-founder and shareholder of Roxbiosens Inc and Implexion AB, and is on the scientific advisory board of Bactolife A/S. K.C. has held a collaborative research contract with Danone Research in the context of the MetaCardis project. D.H.v.R. has participated in advisory boards for AstraZeneca, Boehringer Ingelheim‐Eli Lilly Alliance, MSD, Novo Nordisk and Sanofi, and has received research grants from AstraZeneca, Boehringer Ingelheim‐Eli Lilly Alliance, MSD and Sanofi. All honoraria are paid to the employer of Amsterdam University Medical Centres. All other authors declare to have no related conflict of interest.
: The study was conducted in accordance with the Declaration of Helsinki (updated version 2013).
: All participants provided written informed consent.
: All coauthors read and approved the manuscript.
